Technical Analysis for ENTO - Entero Therapeutics Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Narrow Range Bar | Range Contraction | 7.50% | |
Wide Bands | Range Expansion | 7.50% | |
Up 3 Days in a Row | Strength | 7.50% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 12.82% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 12.82% | |
NR7 | Range Contraction | 12.82% | |
Narrow Range Bar | Range Contraction | 12.82% |
Alert | Time |
---|---|
Up 10% | 1 day ago |
60 Minute Opening Range Breakout | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Up 5% | 1 day ago |
Up 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD, FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Gastrointestinal Disease Gastrointestinal Tract Covid 19
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Gastrointestinal Disease Gastrointestinal Tract Covid 19
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.5 |
52 Week Low | 0.1873 |
Average Volume | 429,187 |
200-Day Moving Average | 2.44 |
50-Day Moving Average | 0.46 |
20-Day Moving Average | 0.57 |
10-Day Moving Average | 0.63 |
Average True Range | 0.09 |
RSI (14) | 61.39 |
ADX | 40.24 |
+DI | 37.22 |
-DI | 13.98 |
Chandelier Exit (Long, 3 ATRs) | 0.58 |
Chandelier Exit (Short, 3 ATRs) | 0.63 |
Upper Bollinger Bands | 0.78 |
Lower Bollinger Band | 0.37 |
Percent B (%b) | 0.77 |
BandWidth | 72.92 |
MACD Line | 0.06 |
MACD Signal Line | 0.05 |
MACD Histogram | 0.0025 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.79 | ||||
Resistance 3 (R3) | 0.79 | 0.76 | 0.78 | ||
Resistance 2 (R2) | 0.76 | 0.73 | 0.76 | 0.77 | |
Resistance 1 (R1) | 0.72 | 0.71 | 0.74 | 0.72 | 0.76 |
Pivot Point | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 |
Support 1 (S1) | 0.65 | 0.66 | 0.67 | 0.65 | 0.61 |
Support 2 (S2) | 0.62 | 0.64 | 0.62 | 0.61 | |
Support 3 (S3) | 0.58 | 0.62 | 0.60 | ||
Support 4 (S4) | 0.58 |